MICHAEL WEINSTEIN: Open Payments
NPI 1750301453 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146 in 7 payments from 6 companies in 2025. Trend: 2023 $233 · 2024 $58 · 2025 $146
Food & beverage: $146
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 1 | $33 |
| Indivior Inc. | 2 | $30 |
| Braeburn Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
Products named: APRETUDE, SUBLOCADE, BRIXADI, TRELEGY ELLIPTA, FASENRA, ZEPBOUND.
Industry payments across PA — which companies pay providers there.
